Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Losing Its Digital Edge And Cybersecurity Are Shuren’s Chief Concerns

Executive Summary

If the US Congress fails to give the Food and Drug Administration the authority it needs to regulate advancing technologies, the country could forfeit its leadership in the digital space to other countries eager to take its place.

You may also be interested in...



News We’re Watching: New CDC Director, Endologix Study Success, Hospital Closure Linked To Ransomware

This week, North Carolina health secretary Mandy Cohen was named the new head of the CDC; Congress debated PAHPA reauthorization; Cala Health launched a Parkinson’s Disease wearable; and IHealth.io was fined for consumer privacy violations.

eSTAR Now Open For PMA Submissions

The US FDA electronic submission process for streamlining its product review process is now available for sponsors submitting some premarket approval applications.

FDA Evaluating Safety Of Plastic Syringes From China, May Prevent Their Import To The US

The US FDA is advising the public that certain plastic syringes from China could fail, leak, or break. If necessary, the agency may prevent Chinese syringes from entering the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel